Abbott Laboratories (ABT) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Abbott Laboratories, as the data feed reports them.

Analysts' mean target, 26 analysts
$118.91
13.6% above the price

The 26 analysts reported by the data feed have a mean price target for Abbott Laboratories of $118.91, 13.6% above the $104.71 price (range $100.00–$130.00). 1.23% of the float was sold short as of Oct 30, 2026. Institutions hold 81.9% of the shares and insiders 0.5%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$118.91+13.6% vs price
Analysts
26
Short interest
1.23%of float, Oct 30, 2026
Short ratio
1.95 days
Institutions
81.9%
Insiders
0.51%
Beta
0.54
Next earnings
Jan 28, 2027estimated

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

26 analysts covering Abbott Laboratories, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $104.71.

Analysts' price targets for Abbott Laboratories
Mean price target$118.9113.6% above the price (+13.6%)
Median price target$120.0014.6% above the price (+14.6%)
Highest target$130.0024.2% above the price (+24.2%)
Lowest target$100.004.5% below the price (−4.5%)
Analysts with a target26

Ratings this month · 28 analysts

Strong buy 5(18%)Buy 18(64%)Hold 5(18%)
Analysts' ratings of Abbott Laboratories this month, by rating
RatingAnalystsShare
Strong buy518%
Buy1864%
Hold518%
Sell00%
Strong sell00%

The feed averages these to 1.54 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns Abbott Laboratories

Ownership of Abbott Laboratories
Held by institutions81.9%3,897 institutions; percent of shares outstanding
Held by institutions, of the float82.4%
Held by insiders0.51%percent of shares outstanding
Shares outstanding1.73B
Float1.72Bshares available to trade
Insiders' net purchases, six months−3.88K2 purchases (400.83K shares), 3 sales (404.71K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Abbott Laboratories
Shares short19.06Mas of Oct 30, 2026
Percent of float1.23%shares short ÷ float
Percent of shares outstanding1.10%shares short ÷ shares outstanding
Short ratio (days to cover)1.95shares short ÷ average daily volume

Abbott Laboratories short interest from FINRA, with its history

Trading figures

Trading figures for Abbott Laboratories
Beta0.54movement against the market; 1 moves with it
52-week high$132.03
52-week low$81.97
Average volume, 3 months8.96Mshares a day
Average volume, 10 days8.77Mshares a day

Dates to know

Upcoming and recent dates for Abbott Laboratories
Next earnings reportJan 28, 2027the feed's estimate, not confirmed
Ex-dividend dateOct 15, 2026as the feed lists it
Dividend payment dateNov 16, 2026

Questions and answers

What is the analysts' price target for Abbott Laboratories (ABT)?

As reported by the data feed, the mean price target of the 26 analysts covering Abbott Laboratories is $118.91, 13.6% above the latest price of $104.71. The highest target is $130.00 and the lowest $100.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Abbott Laboratories stock?

Of the 28 ratings the data feed reports for the current month, 5 are strong buy, 18 buy, 5 hold, 0 sell and 0 strong sell.

How many Abbott Laboratories shares are sold short?

As reported by the data feed, 19.06M shares were sold short, 1.23% of the float as of Oct 30, 2026. At the average daily volume that is 1.95 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Abbott Laboratories stock?

As reported by the data feed, institutions hold 81.9% of the shares (3,897 institutions) and insiders 0.5%. There are 1.73B shares outstanding, of which 1.72B are in the float.

When is Abbott Laboratories's next earnings report?

The data feed lists Jan 28, 2027, marked as its estimate rather than a date the company has confirmed. The latest ex-dividend date it lists is Oct 15, 2026.

How much does Abbott Laboratories stock move with the market?

Its beta, as reported by the data feed, is 0.54: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $81.97 and $132.03.

Cite this page

Funkfolio, “Abbott Laboratories (ABT) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/ABT/statistics

Underlying data: Yahoo Finance.